BioCentury
ARTICLE | Finance

Globe spinning

Why Australian pain play Spinifex is establishing a U.S. beachhead

April 14, 2014 7:00 AM UTC

Australian pain play Spinifex Pharmaceuticals Pty. Ltd. is looking to tap into Northern Hemisphere capital with its $45 million series C round and the establishment of a U.S. base.

Last week's tranched round was led by new investor Novo A/S. New investor Canaan Partners and existing investors GBS Venture Partners, Brandon Capital Partners, Uniseed and UniQuest also participated...